Akshay Vaishnaw, EVP, Chief Medical Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 32,769 shares at $73.34 ($2.4M) on 2014-03-18, disclosed to the SEC on 2014-03-20.
Scheduled sale ($2.4M) by EVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.34 | 8,781 | $644K | 26.6% |
| 2 | $74.08 | 22,044 | $1.6M | 67.4% |
| 3 | $75.15 | 1,944 | $146K | 6.0% |
| Total | $73.95 avg | 32,769 | $2.4M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |